SCHEMBL18992256

SCHEMBL18992256

O=C1C=C(O)C(=O)c2c(Cl)cccc21.O=C1C=C(O)C(=O)c2c(Cl)cccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.54
AURKB Q96GD4 2/20 0.54
KDM4E B2RXH2 4/20 0.49
MAPT P10636 4/20 0.49
RECQL P46063 3/20 0.49
KMT2A Q03164 3/20 0.49
POLB P06746 2/20 0.49
USP2 O75604 2/20 0.49
ATM Q13315 1/20 0.49
CTDSP1 Q9GZU7 1/20 0.49
P4HB P07237 4/20 0.46
MEN1 O00255 2/20 0.46
PABPC1 P11940 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP3A4 P08684 2/20 0.46
HPGD P15428 2/20 0.46
MAPK1 P28482 2/20 0.46
PTPN22 Q9Y2R2 1/20 0.46
BACE1 P56817 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19027708 1.00 AURKA (0.54) AURKAAURKBKDM4EMAPTRECQL
SCHEMBL18992139 0.85 MAPT (0.53) AURKAAURKBKDM4EMAPTRECQL
SCHEMBL29407083 0.85 MAPT (0.53) AURKAAURKBKDM4EMAPTRECQL
SCHEMBL29728494 0.81 MAPT (0.72) AURKAAURKBKDM4EMAPTRECQL
SCHEMBL5175867 0.81 MAPT (0.72) AURKAAURKBKDM4EMAPTRECQL
SCHEMBL25382813 0.78 MAPT (0.49) AURKAAURKBKDM4EMAPTRECQL
SCHEMBL18992112 0.78 ADORA2A (0.53) AURKAAURKBKDM4EMAPTRECQL
SCHEMBL5806124 0.78 MAPT (0.49) AURKAAURKBKDM4EMAPTRECQL
SCHEMBL125609 0.75 NSD2 (0.55) MAPTALDH1A1HPGDMAPK1NSD2
SCHEMBL4585020 0.75 NSD2 (0.55) MAPTALDH1A1HPGDMAPK1PTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10829427-B2 Naphthoquinones, pro-drugs, and methods of use thereof THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2020-11-10 US disclosed
US-20190071380-A1 NAPHTHOQUINONES, PRO-DRUGS, AND METHODS OF USE THEREOF THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-03-07 US disclosed
WO-2017106624-A1 NAPTHOQUINONES, PRO-DRUGS, AND METHODS OF USE THEREOF THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2017-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829427-B2 Naphthoquinones, pro-drugs, and methods of use thereof NQO1, RECQL, ABCB1 AURKA 1252/4885AURKB 692/4885KDM4E 3592/4885
US-20190071380-A1 NAPHTHOQUINONES, PRO-DRUGS, AND METHODS OF USE THEREOF NQO1, RECQL, ABCB1 AURKA 1252/4885AURKB 692/4885KDM4E 3592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.